CLADRIBINE REGIMEN FOR USE INTREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

• 收藏
• 分享

专利权人:

MERCK PATENT GMBH

发明人:

DOTZAUER, Matthias,DANGOND, Fernando

申请号：

SG11202004772R

公开号：

SG11202004772RA

申请日:

2018.11.23

申请国别(地区):

SG

年份:

2020

代理人:

摘要：

Specific oral dosings, specific oral dosage forms, and/or specific oral dose regimens including Cladribine can be effective for the treatment of progressive forms of Multiple Sclerosis, especially Primary Progressive Multiple Sclerosis and/or Secondary Progressive Multiple Sclerosis. Methods of treatment can be based on specific oral dosings, specific oral dosage forms, and/or specific oral dose regimens including Cladribine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/